Revvity, Inc.
Market Cap
12B
Short interest (Jul 15)
6.7%
Net Short (Jul 27 ): 0.0%
Borrow Fee
0.41%
↑ 1.8%
Available Shares
300K
↓ 2.5%
Price Chart
Company Overview
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.